Page last updated: 2024-08-17

quinoxalines and mdl 100907

quinoxalines has been researched along with mdl 100907 in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (14.29)18.2507
2000's4 (57.14)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carlsson, A; Carlsson, ML; Martin, P; Waters, N; Waters, S1
Adell, A; Amargós-Bosch, M; Artigas, F; Bortolozzi, A; Díaz-Mataix, L; Pons, S; Serrats, J1
Greenshaw, A; Hayes, D; Mosher, T1
Gorzalka, BB; Hill, MN; Sun, JC1
Greenshaw, AJ; Hayes, DJ; Mosher, TM1
Aoyama, T; Hattori, T; Kato, S; Kurosawa, S; Nahata, M; Ohno, S; Ro, S; Sakurada, T; Takabayashi, H; Tamai, M; Yakabi, K; Yuzurihara, M1
Chaki, S; Fukumoto, K; Iijima, M1

Other Studies

7 other study(ies) available for quinoxalines and mdl 100907

ArticleYear
MK-801-induced hyperlocomotion: differential effects of M100907, SDZ PSD 958 and raclopride.
    European journal of pharmacology, 1997, Sep-24, Volume: 335, Issue:2-3

    Topics: Animals; Dizocilpine Maleate; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Fluorobenzenes; Hyperkinesis; Male; Mice; Motor Activity; Piperidines; Quinoxalines; Raclopride; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D1; Receptors, Serotonin; Salicylamides; Serotonin Antagonists

1997
In vivo modulation of 5-hydroxytryptamine release in mouse prefrontal cortex by local 5-HT(2A) receptors: effect of antipsychotic drugs.
    The European journal of neuroscience, 2003, Volume: 18, Issue:5

    Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Aminopyridines; Anesthetics, Local; Animals; Antipsychotic Agents; Benzopyrans; Blotting, Western; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Fluorobenzenes; Immunohistochemistry; In Situ Hybridization; Indoles; Indophenol; Male; Mice; Mice, Inbred C57BL; Microdialysis; Piperidines; Prazosin; Prefrontal Cortex; Quinoxalines; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; RNA, Messenger; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Tetrodotoxin; Thiazoles; Time Factors

2003
Differential effects of 5-HT2C receptor ligands on place conditioning and locomotor activity in rats.
    European journal of pharmacology, 2005, May-16, Volume: 515, Issue:1-3

    Topics: Aminopyridines; Animals; Conditioning, Psychological; Dose-Response Relationship, Drug; Indoles; Ligands; Male; Motor Activity; Oxadiazoles; Piperazines; Pyrazines; Pyridines; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT2C; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Time Factors

2005
Functional role of the endocannabinoid system and AMPA/kainate receptors in 5-HT2A receptor-mediated wet dog shakes.
    European journal of pharmacology, 2005, May-23, Volume: 516, Issue:1

    Topics: Amphetamines; Animals; Arachidonic Acids; Behavior, Animal; Cannabinoid Receptor Modulators; Dose-Response Relationship, Drug; Endocannabinoids; Excitatory Amino Acid Antagonists; Injections, Intraperitoneal; Ketanserin; Male; Piperidines; Pyrazoles; Quinoxalines; Rats; Rats, Long-Evans; Receptor, Serotonin, 5-HT2A; Receptors, AMPA; Receptors, Kainic Acid; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Receptor Agonists

2005
Differential effects of 5-HT2C receptor activation by WAY 161503 on nicotine-induced place conditioning and locomotor activity in rats.
    Behavioural brain research, 2009, Feb-11, Volume: 197, Issue:2

    Topics: Aminopyridines; Amphetamine; Animals; Conditioning, Operant; Dopamine Agents; Dose-Response Relationship, Drug; Indoles; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Motor Activity; Nicotine; Nicotinic Agonists; Pyrazines; Quinoxalines; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Reward; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists

2009
Rikkunshito and 5-HT2C receptor antagonist improve cisplatin-induced anorexia via hypothalamic ghrelin interaction.
    Regulatory peptides, 2010, Apr-09, Volume: 161, Issue:1-3

    Topics: Animals; Anorexia; Cisplatin; Drugs, Chinese Herbal; Eating; Gastric Mucosa; Ghrelin; Granisetron; Hypothalamus; Male; Oligopeptides; Ondansetron; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Ghrelin; Reverse Transcriptase Polymerase Chain Reaction; Serotonin 5-HT2 Receptor Antagonists; Stomach

2010
Serotonin-1A receptor stimulation mediates effects of a metabotropic glutamate 2/3 receptor antagonist, 2S-2-amino-2-(1S,2S-2-carboxycycloprop-1-yl)-3-(xanth-9-yl)propanoic acid (LY341495), and an N-methyl-D-aspartate receptor antagonist, ketamine, in the
    Psychopharmacology, 2014, Volume: 231, Issue:11

    Topics: Amino Acids; Animals; Antidepressive Agents; Dioxoles; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Feeding Behavior; Fenclonine; Ketamine; Male; Mice, Inbred C57BL; Neuropsychological Tests; Piperazines; Piperidines; Pyridines; Quinoxalines; Receptors, AMPA; Receptors, Metabotropic Glutamate; Receptors, N-Methyl-D-Aspartate; Ritanserin; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Antagonists; Tryptophan Hydroxylase; Xanthenes

2014